Literature DB >> 15770724

Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population.

Yuan-Zhi Zhang1, Jian-Qiu Sheng, Shi-Rong Li, Hong Zhang.   

Abstract

AIM: To describe systematically the clinical characteristics and phenotype of HNPCC families and the prevalence of HNPCC in the general population of CRC patients in China.
METHODS: HNPCC kindreds and CRC patients were from two sources. One was that we consecutively investigated kindreds and patients by ourselves. And the other was the published Chinese and foreign literature related to Chinese HNPCC syndrome. There were 142 HNPCC families fulfilling AC I and/or AC II including 57 families with detailed data, and 3874 general primary CRC patients in all. All statistical tests were two-sided.
RESULTS: In AC I families, the number of Lynch syndrome I and II families were 25 (47.2%) and 28 (52.8%) respectively. There were 215 patients (82.4%) with CRC, 67 patients (25.7%) with extracolonic cancer and 50 patients (19.2%) with multiple primary cancers. In all CRC patients, multiple primary CRC were in 41 patients (19.1%), and the first-CRC was right-sided colorectal cancer in 143 patients (66.5%) and rectal cancer in 44 patients (20.5%). 8.8% and 19.2% of the first cancer were CRC and extracolonic cancers. Among those patients whose first cancer was CRC, 66.8% and 19.9% were right-sided colorectal cancer and rectal cancer, respectively. The similar results were found in AC II families. Normal distribution was only found in the distribution of the age of diagnosis of the first cancer in both AC I families (coefficient of skewness: u = 0.81, 0.20<0.40<P<0.50; coefficient of kurtosis: u = 1.13, 0.20<P<0.40, alpha = 0.20) and AC II families (coefficient of skewness: u = 0.63, P>0.5>0.20; coefficient of kurtosis: u = 0.84, 0.20<0.40<P<0.50, alpha = 0.20), but not found in the distribution of the age of diagnosis of the first CRC. When patients with HNPCC-associated cancer suffered from the first malignant tumor in HNPCC families diagnosed by AC I and AC II, the mean age and median age were 45.1+/-12.7 years and 44.0 years, 45.2+/-12.7 years and 44.5 years, respectively. The median age of diagnosis of the first tumor of the patients in the later generation was younger than that in the previous generation. Many extracolonic cancers were found to be associated with HNPCC syndrome. Gastric cancer was the most frequent extracolonic cancer followed by endometrial cancer and hepatocarcinoma. In general population of CRC patients, the prevalence of HNPCC diagnosed by AC I and AC II were 1.3% and 2.2%, respectively.
CONCLUSION: The clinical phenotype and prevalence of Chinese HNPCC syndrome are similar to those of Europeans and Americans. Gastric cancer is the most common extracolonic malignant tumor. The age of diagnosis of the first malignant tumor tends to be increasingly younger in patients with HNPCC-related tumors.

Entities:  

Mesh:

Year:  2005        PMID: 15770724      PMCID: PMC4305690          DOI: 10.3748/wjg.v11.i10.1481

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.

Authors:  E Mangold; C Pagenstecher; M Leister; M Mathiak; A Rütten; W Friedl; P Propping; T Ruzicka; R Kruse
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.

Authors:  D J Peel; A Ziogas; E A Fox; M Gildea; B Laham; E Clements; R D Kolodner; H Anton-Culver
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

Review 3.  The role of proteomics in the diagnosis and outcome prediction in colorectal cancer.

Authors:  R Steinert; T Buschmann; M van der Linden; L M Fels; H Lippert; M A Reymond
Journal:  Technol Cancer Res Treat       Date:  2002-08

Review 4.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer.

Authors:  P Peltomäki
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome.

Authors:  M Aarnio; R Salovaara; L A Aaltonen; J P Mecklin; H J Järvinen
Journal:  Int J Cancer       Date:  1997-10-21       Impact factor: 7.396

6.  [Registration of hereditary non-polyposis colorectal cancer].

Authors:  I T Bernstein; M L Bisgaard; T Myrhøj
Journal:  Ugeskr Laeger       Date:  1999-11-08

7.  Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum.

Authors:  Claudio Soravia; Heleen van der Klift; Marie-Anne Bründler; Jean-Louis Blouin; Juul Wijnen; Pierre Hutter; Riccardo Fodde; Célia Delozier-Blanchet
Journal:  Am J Med Genet A       Date:  2003-08-30       Impact factor: 2.802

8.  Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations.

Authors:  P Peltomäki; X Gao; J P Mecklin
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

9.  Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation?

Authors:  C L Marcelis; H W van der Putten; C Tops; L C Lutgens; U Moog
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

10.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  15 in total

1.  Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status.

Authors:  Jeong Mo Bae; Mi Jung Kim; Jung Ho Kim; Jae Moon Koh; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2011-04-15       Impact factor: 4.064

Review 2.  [Prophylactic surgery for hereditary non-polyposis colorectal cancer].

Authors:  G Möslein; C Ohmann; M Wenzel
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

3.  Familial adenomatous polyposis in China.

Authors:  Jun Yang; Qing Wei Liu; Liang Wen Li; Qiang Zhi Wang; Min Hong; Jian Dong
Journal:  Oncol Lett       Date:  2016-10-31       Impact factor: 2.967

4.  The liver: another organ involved in Muir Torre syndrome?

Authors:  F Morando; M Alaibac; A Romano; M Cavallin; S Piano; M Pizzi; C Mescoli; P Pilati; A Gatta; P Angeli
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 5.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

6.  The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.

Authors:  Susan Stuckless; Patrick S Parfrey; Michael O Woods; Janet Cox; G William Fitzgerald; Jane S Green; Roger C Green
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

7.  Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.

Authors:  A Gylling; W M Abdel-Rahman; M Juhola; K Nuorva; E Hautala; H J Järvinen; J-P Mecklin; M Aarnio; P Peltomäki
Journal:  Gut       Date:  2007-01-31       Impact factor: 23.059

8.  Hereditary colorectal cancer in china.

Authors:  Zheng Shu; Huang Yanqin; Yuan Ying
Journal:  Hered Cancer Clin Pract       Date:  2005-11-15       Impact factor: 2.857

9.  Cancer genetic counseling communication with low-income Chinese immigrants.

Authors:  Janice Ka Yan Cheng; Claudia Guerra; Rena J Pasick; Dean Schillinger; Judith Luce; Galen Joseph
Journal:  J Community Genet       Date:  2017-12-01

10.  Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.

Authors:  Lei Fu; Jian-qiu Sheng; Xiao-ou Li; Peng Jin; Hong Mu; Min Han; Ji-sheng Huang; Zi-qin Sun; Ai-qin Li; Zi-tao Wu; Shi-rong Li
Journal:  Cell Oncol (Dordr)       Date:  2013-05-03       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.